BioHealth News Archive
Virginia Outstanding Contribution to Life Science Inducts Three Award Winners
Virginia Bio, the premier statewide non-profit trade association representing the life sciences industry in the Commonwealth of Virginia, announced on May 2, 2019, during…
Read MoreProtenus raises $13 million in new funding round
Protenus, a Baltimore data security company, has raised $13 million in new equity financing, according to documents filed with the U.S. Securities and Exchange…
Read MoreThe Rise of Bio Health Innovation Districts
By: Brian Darmody, CEO, Association of University Research Parks (AURP) Across the country and around the world, cities, research universities, government labs and other…
Read MoreNew SBIR/STTR Rules Moving Forward – Lexology
On April 2, 2019, the U.S. Small Business Administration (SBA) issued a new Policy Directive for the Small Business Innovation Research (SBIR) and the…
Read MoreBIO Continues Partnership with NIH for Fifth “Innovation Zone” Exhibit
The Biotechnology Innovation Organization (BIO) and the National Institutes of Health (NIH) today announced an agreement to feature Small Business Innovation Research (SBIR)-funded early-stage…
Read MoreVA researchers develop biomarkers, blood test that shows MS patients in relapse – EurekAlert! Science News
Dr. Horea Rus is an expert in diagnosing and treating patients with multiple sclerosis, and his research laboratory at the University of Maryland is…
Read MoreGaithersburg-based Sirnaomics closes $47 million funding round – BioBuzz
Sirnaomics Inc. has taken in yet another $11 million in investments, closing a Series C funding round that totaled $47 million. The Gaithersburg biopharmaceutical…
Read MoreFDA approves first pediatric lupus treatment
The US FDA approves an extended indication of GSK’s lupus treatment, Benlysta IV, for children five years and older, giving pediatric patients a new…
Read MoreThe Journey To Commercialization for a Novel Medical Device Startup: Q&A with Sonavex CEO, David Narrow · BioBuzz
In the past year Sonavex has landed not one, but two FDA 510(k) clearances for their ultrasound-based medical devices. This first of its kind…
Read MoreMedImmune-lite? Immunocore delves into British Big Pharma’s R&D talent pool, again | FierceBiotech
Bahija Jallal, David Berman, Koustubh Ranadel, and now Mohammed Dar lines up as the latest AstraZeneca/MedImmune executive to jump ship into U.K. biotech Immunocore.…
Read MoreThree Examples That Show Why NCI is a Goldmine of Blockbuster Technologies for Commercialization · BioBuzz
What do the technologies that led to the success of Kite Pharma, the creation of the pioneering immune-oncology cancer treatment avelumab (BAVENCIOⓇ) and the…
Read MoreWhy Paragon Bioservices’ $1.2B acquisition deal matters to Baltimore – Technical.ly Baltimore
For Paragon Bioservices, news came quickly earlier this month. On a Thursday in mid-April, Gov. Larry Hogan and other state and county officials joined…
Read MoreFDA clears RemUnity drug pump co-developed by Deka, United Therapeutics
United Therapeutics and Deka Research and Development have received FDA 510(k) clearance for the co-developed RemUnity system. The RemUnity system is a subcutaneous delivery…
Read MoreWith promising pivotal data, Viela Bio’s lead autoimmune drug heads for FDA filing – FierceBiotech
Viela Bio spun out of AstraZeneca last year with six autoimmune and inflammation-aimed programs and $250 million. Now, the biotech is reporting positive pivotal…
Read MoreFastForward exits show success of Hopkins incubator – Maryland Daily Record
Two years after Johns Hopkins Technology Ventures opened new office and lab space for its FastForward 1812 incubator on the Johns Hopkins Hospital campus,…
Read More